Use of new Alzheimer's drug is limited in the US

 


 WASHINGTON - A month after approving a new drug to treat Alzheimer's disease, US regulators on Thursday issued new prescribing instructions that will likely limit its use.

 The Food and Drug Administration (FDA) said the goal of the change is to respond to confusion among doctors and patients about who should use the drug, whose approval last month sparked an intense backlash.

Post a Comment

We want to know your comments and concerns. Remember: Respect distinguishes us, education makes us different...

Previous Post Next Post